J&J Vaccine Fallout for Reopening Stocks

As concerns over the J&J vaccine hits some stocks, others near record highs, Scott Wapner and the Investment Committee weigh in on what it could mean for this record run. Plus, Altimeter Capital’s Brad Gerstner joins us to talk about his latest SPAC deal, the biggest one ever. We’ll also get his thoughts on the market and where it can go from here.